Modulation of gene expression and tumor cell growth by redox modification of STAT3

Li Li1, Shing-Hu Cheung, Emma L Evans

  • 1School of Biomedical Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom.

Cancer Research
|September 3, 2010
PubMed

Insights

Reactive oxygen species (ROS) impact tumor growth by altering signal transducer and activator of transcription 3 (STAT3). Oxidizing STAT3 cysteine residues inhibits its DNA binding, affecting cell proliferation and survival.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Reactive oxygen species (ROS) are known to promote tumor cell proliferation and survival.
  • The signal transducer and activator of transcription 3 (STAT3) pathway is constitutively active in many cancer types.
  • Previous studies have explored the effects of ROS on the Janus kinase/STAT pathway.

Purpose of the Study:

  • To investigate the direct sensitivity of STAT3 to intracellular oxidants.
  • To determine how ROS-mediated oxidation of STAT3 affects its function and downstream signaling.
  • To elucidate the role of STAT3 in coupling cellular redox state to proliferation and survival.

Main Methods:

  • In vitro and in vivo experiments assessing STAT3 binding to serum-inducible elements (SIE) after peroxide treatment.
  • Reporter gene assays to measure interleukin (IL)-6-mediated gene expression.
  • Utilizing redox-insensitive STAT3 mutants to negate oxidation effects.
  • Expression of redox-insensitive STAT3 in breast carcinoma cells.

Main Results:

  • Oxidation of conserved cysteines in STAT3 by peroxide decreased its binding to SIE both in vitro and in vivo.
  • Interleukin (IL)-6-mediated reporter expression was diminished due to cysteine oxidation.
  • Inhibitory effects of cysteine oxidation were abolished in redox-insensitive STAT3 mutants.
  • ROS did not affect IL-6-induced STAT3 recruitment to the c-myc P2 promoter.
  • Expression of redox-insensitive STAT3 in breast cancer cells led to accelerated proliferation and reduced resistance to oxidative stress.

Conclusions:

  • STAT3 is directly sensitive to intracellular oxidants, with cysteine oxidation inhibiting its DNA-binding activity.
  • STAT3 plays a crucial role in linking intracellular redox homeostasis to cancer cell proliferation and survival.
  • Targeting STAT3's redox sensitivity could offer novel therapeutic strategies for cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...